Trial Profile
Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 24 Aug 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Epidermolysis bullosa
- Focus Therapeutic Use
- Acronyms EBTox
- 22 Aug 2023 Planned End Date changed from 1 Jun 2023 to 1 Dec 2023.
- 22 Aug 2023 Planned primary completion date changed from 1 Jun 2022 to 1 Sep 2023.
- 03 Sep 2021 Planned End Date changed from 1 Jun 2022 to 1 Jun 2023.